Bridgefront Capital, LLC Bio Techne Corp Transaction History

Bridgefront Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$62.12 - $84.15 $206,921 - $280,303	3,331 Added 53.49%	9,558 $684,000
Q1 2024 May 15, 2024	BUY	$65.98 - $77.09 $410,857 - $480,039	6,227 New	6,227 $438,000
Q3 2023 Nov 14, 2023	BUY	$67.52 - $89.42 $57,999 - $76,811	859 Added 33.85%	3,397 $231,000
Q2 2023 Aug 14, 2023	BUY	$73.76 - $85.98 $187,202 - $218,217	2,538 New	2,538 $207,000
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $243,462 - $1.06 Million	3,018 New	3,018 $250,000

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.94B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.